急性淋巴细胞白血病分子遗传学异常及靶向治疗
摘要
染色体异常导致的分子遗传学异常是急性淋巴细胞白血病（ALL）的一个重要致病因素和独立预后指标。对ALL发病机制进行分子水平的探索，将使人们更深入理解疾病的本质，并为靶向药物的研发提供新的思路。本文将近年来在此领域的研究进展作一综述。
出处
《国际输血及血液学杂志》
CAS
2009年第1期70-73,共4页
International Journal of Blood Transfusion and Hematology
基金
基金项目：广州市科技攻关计划-科技攻关引导项目（200623-E0401）
参考文献19
-
1Pui CH,Relling MV, Downing JR, et al. Acute lymphoblastic leukemia. N EnglJ Med,2004,350(15):1535-1548.
-
2Pui CH, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov,200? ,6(2): 149-165.
-
3Thomas X, Le QH. Prognostic factors in adult acute lymphoblastic leukemia. Hematology, 2003,8(4):233-242.
-
4Primo D,Tabernero MD, Perez JJ, et al. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics. Leukemia, 2005,19(5): 713-720.
-
5Soverini S,Colarossi S,Gnani A,et al. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of philadelphia-positive patients: by the GIMEMA working party on chronic myeloid leukemia. Clin Cancer Res, 2006, 12 ( 24 ) : 7374- 7379.
-
6Pfeifer H, Wassmann B, Pavlova A, et al. Kinase domain mutations of BCR AB1. frequentlyprecede imatinib-based therapy and give rise to relapse in patients with de novo philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood, 2007, 110 (2): 727- 734.
-
7Piccaluga PP,Paolini S, Martinelli G. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Cancer,2007,110(6) :1178-1186.
-
8Zelent A, Greaves M, Enver T. Role of the TEL AMIA fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene,2004,23(24): 4275-4283.
-
9Tsuzuki S, Karnan S, Horibe K,et al. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer Sci,2007,98(5) :698-706.
-
10Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B precursor acute leu kemias:dominance of HOX dysregulation. Blood, 2003, 102 ( 1 ): 262-268.
-
1卞修武.人类胶质瘤染色体改变和分子遗传学异常[J].国外医学（遗传学分册）,1997,20(5):251-256. 被引量：1
-
2戈霞晖,张锦.染色体异常与肺癌的关系[J].国际呼吸杂志,2005,25(S1):48-51.
-
3周细龙,吴名珗,李宗浩.白血病的染色体异常[J].上海医学检验杂志,1993,8(3):181-183.
-
4吴秋方,李天铎.人类肿瘤本质之思考[J].医学与哲学,1991,12(11):1-4. 被引量：8
-
5陈琪,刘晓力,周淑芸.非霍奇金淋巴瘤染色体异常及其临床意义[J].白血病．淋巴瘤,2004,13(5):319-320.
-
6陈永春,范磊,徐卫,李建勇.套细胞淋巴瘤诊断和治疗进展[J].临床血液学杂志,2016,29(3):424-427. 被引量：6
-
7覃靖,张成.人类肿瘤与染色体异常的研究[J].广西医学,1995,17(6):515-517.
-
8周容,卢洁,孙立荣,董增义,谷仁凯,佟琳如.小儿急性白血病的细胞遗传学研究[J].青岛医学院学报,1994,30(4):276-279.
-
9周立宇,常春康,张征,吴凌云,李晓,浦权.i(9q)染色体异常的急性淋巴细胞白血病1例报告附文献复习[J].诊断学理论与实践,2009,8(5):547-549.
-
10彭芳,周志姣,朱建思.人结直肠癌侵袭及转移机制研究进展[J].医学临床研究,2006,23(8):1273-1275. 被引量：1
